Aurora strengthens leadership position in germany with eu-gmp certification at preeminent local cannabis production facility

State-of-the-art facility readying first delivery of medical grade cannabis for german patients edmonton, ab , may 18, 2022 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), the canadian company defining the future of cannabinoids worldwide, announced today the company has received eu-gmp certification for its state-of-the-art medical cannabis production facility in germany. as a leading manufacturer of medical cannabis worldwide, achieving eu-gmp certification of the company's first german manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the german federal institute for drugs and medical devices (bfarm).
ACB Ratings Summary
ACB Quant Ranking